You are here: Industry Insights > PD

News List

Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's Global Phase II Clinical Trial in Treating Parkinson's Disease prnasia
January 17, 2022
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational New Drug (IND) application for the global multi-center phase-II clinical trial of Oligomannate...
KOL Views Preview: AbbVie’s ABBV-951 works but will PD patients use it? FirstWordPharma
November 01, 2021
ABBV-951 was expected to work better than oral levodopa/carbidopa and it did not disappoint in a Phase III trial for advanced Parkinson’s disease (PD).
Teva, Modag to develop drug candidates for neurodegenerative disease Pharmaceutical-Business-Review
October 29, 2021
Teva Pharmaceutical has partnered with Modag for the development and licensing of the latter’s drug candidates, anle138b and sery433, for neurodegenerative disease.
Parkinson’s disease market sales to reach $11.5 billion in 2029 europeanpharmaceuticalreview
August 12, 2021
The Parkinson’s disease market is set to triple in sales by 2029 driven by novel biologics and delivery systems, reports GlobalData.
US grants new patent targeting major neurodegenerative diseases europeanpharmaceuticalreview
July 05, 2021
Alterity Therapeutics have been granted a patent for compounds able to redistribute excess iron in the brain being developed as a treatment for neurodegenerative diseases including Alzheimer’s and Parkinson’s.
Scientists at IIT Madras identify energy deficiency in brain cells as major cause for Parkinson’s Disease expresspharma
March 11, 2021
The novel findings of this research may enhance understanding of the pathophysiology of Parkinson’s Disease and might finally lead to a cure.
GB Sciences Announces Results from Parkinson's Disease Study americanpharmaceuticalreview
December 23, 2019
GB Sciences announced preclinical results for their Parkinson's disease (PD) formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of ...
Antibiotic Exposure May Be Tied to Risk for Parkinson Disease drugs
December 19, 2019
Exposure to certain types of oral antibiotics may be associated with an elevated risk for Parkinson disease (PD), according to a study published online in Movement Disorders.
Expansion of Peritoneal Dialysis Feasible drugs
September 12, 2019
Expansion of the use of peritoneal dialysis (PD) is feasible, according to a study published online in JAMA Internal Medicine.
Vitamin D Tied to Falls, Nonmotor Symptoms in Parkinson Disease drugs
August 12, 2019
In patients with Parkinson disease (PD), vitamin D levels are significantly correlated with falls and some nonmotor symptoms, according to a study published online in Acta Neurologica Scandinavia.

Previous page 1 2 Next page